Impact of the polycarbonate strippers used in assisted reproduction techniques on embryonic development.


Journal

Human reproduction (Oxford, England)
ISSN: 1460-2350
Titre abrégé: Hum Reprod
Pays: England
ID NLM: 8701199

Informations de publication

Date de publication:
25 01 2021
Historique:
received: 28 04 2020
revised: 21 09 2020
pubmed: 28 11 2020
medline: 26 5 2021
entrez: 27 11 2020
Statut: ppublish

Résumé

Do daily manipulations of preimplantation embryos with polycarbonate (PC)-made bisphenol A (BPA)-releasing strippers influence embryo development? Compared to glass strippers, PC strippers enhance the blastocyst development rate but this does not seem to be BPA-related. PC strippers have been shown to release tiny amounts (around 0.5 ng/ml BPA) of BPA in routine human IVF procedures. A chronic exposure to BPA either in vivo or in vitro during the preimplantation period can impact post-implantation and post-natal development. BPA can act rapidly by binding to membrane receptors and inducing rapid non-genomic effects. This experimental study using mouse embryos had a balanced design and blinded evaluations of the endpoints. In vivo fertilized zygotes were obtained from outbred Swiss CD1 mice crossings after an ovarian stimulation. The zygotes were allocated to three daily handling conditions (HCs) and cultured until Day 4 in a single human commercial medium. Each day, the embryos were handled for 20 s either in a PC stripper (HC1) or in a glass stripper (HC2). In HC3, the embryos were pre-exposed to 0.5 ng/ml BPA before being handled for 20 s in a glass stripper. Handling operations were repeated on Days 1, 2 and 3. Embryo development was assessed blindly on Day 4. Expanded blastocysts were selected for a transcriptomic analysis using Agilent Sureprint G3 Mouse GE v2 microarrays and the retrotransposon LINE1-Orf2 expression was analysed using qRT-PCR, as a proxy for a global evaluation of the epigenetic status. Compared to the embryos manipulated in HC2 (n = 243), those in HC1 (n = 228) developed significantly more often to the blastocyst stage (55 vs 46%; P < 0.05). It appears the effect of these PC strippers was not BPA-related because embryos pre-exposed to BPA (HC3, n = 230) showed no difference in the blastocyst rate when compared to HC2 (43 vs 46%). When analysing same-stage blastocysts, we noticed no difference in the embryo gene expression between the three HC groups. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE148868. Our results using a mouse model designed to mimic human conditions (outbred strain, human commercial IVF dishes and a unique commercial human embryonic culture media) are reassuring since no gene was found to be differentially expressed, including LINE-1 genes, as a proxy for a global evaluation of the epigenetic status. However, no global epigenetic analysis of the genome has been performed. Furthermore, we did not evaluate post-implantation events, although BPA exposure during peri-conception could affect foeto-placental and post-natal development. Based on the precautionary principle, several European countries banned the use of BPA in baby bottles and food packaging several years before European Agencies took an official position. The question of applying this principle to plastics in closed contact with human embryos is raised. Further studies are needed for a decision to be made. This study was supported by a grant from the Agence de Biomédecine (AOR 2016). The authors declare no competing interest.

Identifiants

pubmed: 33246333
pii: 6007757
doi: 10.1093/humrep/deaa290
doi:

Substances chimiques

Polycarboxylate Cement 0
polycarbonate 25766-59-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

331-339

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

J Moreau (J)

Department of Reproductive Medicine, Toulouse University Hospital, Toulouse, France.
EA 3694 Human Fertility Research Group, Paul Sabatier University, Toulouse, France.

N Gatimel (N)

Department of Reproductive Medicine, Toulouse University Hospital, Toulouse, France.
EA 3694 Human Fertility Research Group, Paul Sabatier University, Toulouse, France.

Y Lippi (Y)

Toxalim (Research Center in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, UPS, Toulouse, France.

G Tavenier (G)

Transgenesis core facility of UMS006/Inserm/Paul Sabatier University/National Medical Veterinary School, Toulouse cedex 1, France.
Inserm UMR 1048, Paul Sabatier University, Toulouse cedex 4, France.

P Fauque (P)

Université Bourgogne Franche-Comté-Equipe Génétique des Anomalies du Développement (GAD) INSERM UMR 1231, Dijon, France.
CHU Dijon Bourgogne, Laboratoire de Biologie de la Reproduction, Dijon, France.

M Guilleman (M)

Université Bourgogne Franche-Comté-Equipe Génétique des Anomalies du Développement (GAD) INSERM UMR 1231, Dijon, France.
CHU Dijon Bourgogne, Laboratoire de Biologie de la Reproduction, Dijon, France.

C Naylies (C)

Toxalim (Research Center in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, UPS, Toulouse, France.

A A Huesca (AA)

INTHERES, Université de Toulouse, INRAE, ENVT, INP-Purpan, UPS, Toulouse, France.

V Gayrard (V)

ToxAlim (Research Centre in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, UPS, Toulouse, France.

J Parinaud (J)

Department of Reproductive Medicine, Toulouse University Hospital, Toulouse, France.
EA 3694 Human Fertility Research Group, Paul Sabatier University, Toulouse, France.

R D Leandri (RD)

Department of Reproductive Medicine, Toulouse University Hospital, Toulouse, France.
EA 3694 Human Fertility Research Group, Paul Sabatier University, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH